found that SARS‐CoV‐2 infection induced a significant increase in TF activity on the surface of circulating EVs in vivo, and that this activity correlated with disease severity and may be associated with thrombosis in COVID‐19 patients (Rosell et al., 2021). This evidence concerns the gene TF and Venous thrombosis.